Kurinomaru Takaaki, Shiraki Kentaro
Faculty of Pure and Applied Sciences, University of Tsukuba, Tsukuba, Ibaraki, 305-8573, Japan.
J Pharm Sci. 2015 Feb;104(2):587-92. doi: 10.1002/jps.24217. Epub 2014 Oct 29.
Noncovalent PEGylation has great potential for stabilization of therapeutic proteins. Here, we demonstrated that the noncovalent PEGylation with a PEGylated polyelectrolyte stabilized a therapeutic protein, l-asparaginase (ASNase). Anionic ASNase and cationic poly(ethylene glycol)-block-poly(N,N-dimethylaminoethyl methacrylate) (PEG-b-PAMA) formed a water-soluble protein-polyelectrolyte complex (PPC) without loss of secondary structure and enzyme activity. PPC with PEG-b-PAMA successfully inhibited the shaking-induced inactivation and aggregation of ASNase as well as protease digestion, corresponding to the behaviors of covalently PEGylated ASNase. Thus, noncovalent PEGylation by PEGylated polyelectrolytes is a new candidate for handling of therapeutic proteins.
非共价聚乙二醇化在治疗性蛋白质的稳定化方面具有巨大潜力。在此,我们证明了用聚乙二醇化聚电解质进行的非共价聚乙二醇化能够稳定一种治疗性蛋白质——L-天冬酰胺酶(ASNase)。阴离子型ASNase与阳离子型聚(乙二醇)-嵌段-聚(N,N-二甲基氨基乙基甲基丙烯酸酯)(PEG-b-PAMA)形成了一种水溶性蛋白质-聚电解质复合物(PPC),且二级结构和酶活性均未丧失。含有PEG-b-PAMA的PPC成功抑制了ASNase因振荡引起的失活和聚集以及蛋白酶消化,这与共价聚乙二醇化ASNase的行为相符。因此,聚乙二醇化聚电解质介导的非共价聚乙二醇化是处理治疗性蛋白质的一种新选择。